Literature DB >> 17156272

A generalized response surface model with varying relative potency for assessing drug interaction.

Maiying Kong1, J Jack Lee.   

Abstract

When multiple drugs are administered simultaneously, investigators are often interested in assessing whether the drug combinations are synergistic, additive, or antagonistic. Based on the Loewe additivity reference model, many existing response surface models require constant relative potency and some of them use a single parameter to capture synergy, additivity, or antagonism. However, the assumption of constant relative potency is too restrictive, and these models using a single parameter to capture drug interaction are inadequate to describe the phenomenon when synergy, additivity, and antagonism are interspersed in different regions of drug combinations. We propose a generalized response surface model with a function of doses instead of one single parameter to identify and quantify departure from additivity. The proposed model can incorporate varying relative potencies among multiple drugs as well. Examples and simulations are given to demonstrate that the proposed model is effective in capturing different patterns of drug interaction.

Mesh:

Substances:

Year:  2006        PMID: 17156272     DOI: 10.1111/j.1541-0420.2006.00579.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  18 in total

1.  A semiparametric response surface model for assessing drug interaction.

Authors:  Maiying Kong; J Jack Lee
Journal:  Biometrics       Date:  2007-09-26       Impact factor: 2.571

Review 2.  Assessment of non-linear combination effect terms for drug-drug interactions.

Authors:  Gilbert Koch; Johannes Schropp; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-16       Impact factor: 2.745

3.  Confidence Intervals of Interaction Index for Assessing Multiple Drug Interaction.

Authors:  J Jack Lee; Maiying Kong
Journal:  Stat Biopharm Res       Date:  2009-02-01       Impact factor: 1.452

Review 4.  Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.

Authors:  Lindsay K Caesar; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-06-19       Impact factor: 13.423

5.  Feasibility of Exposure-Response Analyses for Clinical Dose-Ranging Studies of Drug Combinations.

Authors:  Theodoros Papathanasiou; Anders Strathe; Andrew C Hooker; Trine Meldgaard Lund; Rune Viig Overgaard
Journal:  AAPS J       Date:  2018-04-23       Impact factor: 4.009

6.  Assessing interactions for fixed-dose drug combinations in tumor xenograft studies.

Authors:  Jianrong Wu; Lorraine Tracey; Andrew M Davidoff
Journal:  J Biopharm Stat       Date:  2012       Impact factor: 1.051

7.  Monotonic single-index models to assess drug interactions.

Authors:  Yubing Wan; Susmita Datta; J Jack Lee; Maiying Kong
Journal:  Stat Med       Date:  2016-11-02       Impact factor: 2.373

8.  Drug interaction: focusing on response surface models.

Authors:  Soo-Il Lee
Journal:  Korean J Anesthesiol       Date:  2010-05-29

9.  Assessing interactions for fixed-dose drug combinations in subcutaneous tumor xenograft studies.

Authors:  Jianrong Wu
Journal:  Pharm Stat       Date:  2013-03-07       Impact factor: 1.894

10.  Nonlinear response surface in the study of interaction analysis of three combination drugs.

Authors:  Wen Wan; Xin-Yan Pei; Steven Grant; Jeffrey B Birch; Jessica Felthousen; Yun Dai; Hong-Bin Fang; Ming Tan; Shumei Sun
Journal:  Biom J       Date:  2016-05-17       Impact factor: 2.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.